QWM
REVBW icon

Quaker Wealth Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Quaker Wealth Management’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Hold
387
– – ﹤0.01% 967
2026
Q1 		$3 Hold
387
– – ﹤0.01% 972
2025
Q4 		$4 Hold
387
– – ﹤0.01% 965
2025
Q3 		$5 Hold
387
– – ﹤0.01% 839
2025
Q2 		$5 Buy
+387
New +$5 ﹤0.01% 866

Other funds holding REVBW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SIA
Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Quaker Wealth Management's REVBW Position: Q2 2026 in Review

Quaker Wealth Management held its Revelation Biosciences Warrant (REVBW) position steady in Q2 2026 at 387 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Quaker Wealth Management first reported a position in REVBW in Q2 2025 and has held it in 5 quarters since. The position peaked at $5 in Q3 2025. 13 funds tracked by Wall St. Rank hold REVBW as of Q2 2026.

  • Quaker Wealth Management held 387 shares of Revelation Biosciences Warrant worth $4 as of Q2 2026.
  • Quaker Wealth Management left its Revelation Biosciences Warrant share count unchanged in Q2 2026.
  • Revelation Biosciences Warrant made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #967 holding.
  • Quaker Wealth Management first reported a position in Revelation Biosciences Warrant in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's Revelation Biosciences Warrant position peaked at $5 in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.